Questions and answers clinic on post-authorisation procedure management in IRIS - 17 Jan 2025

Date

, -

Location

Online

Event summary

In January 2025, the following EMA-led procedures will transition to IRIS for all Centrally Authorised Products (CAPs) (and involved non-CAPs) for procedures submitted on/ after 20 December 2024 via the current submission systems (i.e. Gateway and PSUR repository):

  • Post-Authorisation Measures
  • Line Extensions
  • Renewals
  • Annual Reassessments
  • Post-Authorisation Safety Studies/Post-Marketing Surveillance Studies
  • Referrals

The first transition of post-authorisation procedures to IRIS took place on 23 January 2024, onboarding variations, Article 61.3 notifications, and marketing authorisation (MA) transfer procedures for a subset of human and veterinary CAPs with low regulatory complexity. 

Note: Periodic Safety Update Reports will transition to IRIS with the procedures starting on the 6 February 2025 and onwards as per PSUR procedural timetable.

Video recording is published after the event.

Video recording

Documents

Share this page